+380 63 419 0122
caslinkllc@gmail.com |
Business Type | Exporter, Supplier, Retailer, Wholesaler, Trader, Distributor |
Packaging Type | Boxes |
Brand Name | Ponatinib |
Dosage Form | Tablets |
Click to view more |
Preferred Buyer From
Location | All Countries |
Product Details
Ponatinib is a kinase inhibitor indicated for the treatment of adult patients with chronic phase, accelerated phase or blast phase chronic myeloid leukemia ( CML) that is resistant or intolerant to prior TKI therapy or philadelphia chromose positive acute lymbhoblastic leukemia (PH+ ALL) that is resistant or intolerant to prior TKI therapy
Hi! Simply click below and type your query.
Our experts will reply you very soon.